Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 21, 2019
MolecularMD, a molecular diagnostic specialty laboratory that enables the development and commercialization of precision medicines in oncology, has been acquired by ICON.
read more
Catalent welcomed the news from Nocion Therapeutics that its first patient has been dosed with NOC-100, an inhaled formula of its NTX-1175 small molecule candidate.
read more
Thursday, October 14, 2021
Alcami announced the appointment of Chad Bovero, James Fife, and Tobin Cowart to their senior leadership team. Chad Bovero has been appointed to the role of Vice President, Charleston Sterile Operations.
read more
Friday, December 07, 2012
Ken Phelps, one of the nation’s leading experts in the 505(b)(2) development pathway, will be a keynote speaker at the EPPIC Annual Conference in San Francisco, January 6.
read more
Ben Venue Laboratories. Inc. (“Ben Venue”), a member of the Boehringer Ingelheim Group of Companies, announced today that the company has signed an asset purchase agreement for the sale of the assets of Bedford Laboratories, Ben Venue’s U.S. ...
read more
Tuesday, February 03, 2015
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), a division of Consort Medical plc, today announces it has received continuing FDA approvals for both its bulk manufacturing and packaging operations in ...
read more
Evotec has announced a multi-year compound management agreement with Pierre Fabre Laboratories, the second largest private French pharmaceutical group.
read more
Monday, February 08, 2021
Immunome announced that Abzena was selected as Immunome’s partner research organization for IMM-BCP-01, an investigational therapeutic antibody cocktail for the treatment of COVID-19 being developed to target multiple SARS-CoV-2 antigens.
read more
Wednesday, April 10, 2024
Ascend Advanced Therapies has acquired the CMC team and site in Alachua, Florida from Beacon Therapeutics. The transaction brings an operational good manufacturing practice (GMP) facility, process and analytical development capabilities, and ...
read more
Cambrex has completed a new 600 m2 facility at its site in Karlskoga, Sweden, which incorporates new laboratories for process and analytical development.
read more
Monday, February 10, 2020
Certara announced its discovery research relationship with Arvinas has expanded to include a greater diversity of small molecule drug discovery projects and data sources.
read more
Wednesday, December 09, 2020
Stelis BioSource has started the next phase of its continued investment program after having already invested well over $100m into its facilities in Bangalore, India.
read more
Thursday, January 07, 2021
Avacta Group has entered into a license agreement with POINT to provide access to Avacta’s pre|CISION technology for the development of tumor-activated radiopharmaceuticals.
read more
Cellipont Bioservices announced the grand opening of its purpose-built 76,000 sq. ft. manufacturing facility in The Woodlands, TX. This facility includes 7 clean rooms, QC labs, temperature-controlled storage, segregated shipping bays, warehouse, and...
read more
Hamilton Health Care System and Baxter International announced Hamilton is the first health system in the U.S. to use Baxter’s new PrisMax system.
read more